# Correction: Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials

**Authors:** Andrea Messori, Roberto Brunoro, Maria Gabriella Paolì, Melania Rivano

PMC · DOI: 10.7759/cureus.c411 · 2026-03-06

## Full-text entities

- **Diseases:** Pulmonary Arterial Hypertension (MESH:D000081029)
- **Chemicals:** Selexipag (MESH:C523468)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12966618